Acacia Research
North America, New York, United States, New York
Description
Acacia Research, through its subsidiaries, acquires, develops, licenses, and enforces patented technologies in the United States.
Investor Profile
Acacia Research has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series Unknown (60%)
- Series A (20%)
- Series B (20%)
Country Focus
- United States (60%)
- United Kingdom (40%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical Device
- Clinical Trials
- Medical
- Therapeutics
- Genetics
- Health Diagnostics
- Data Integration
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
